H A V N & Company

H A V N & Company Chartered Accountants

03/03/2026

🚀 Eligible Manufacturer Importer (EMI) Scheme – A Game Changer for Importing Manufacturers

The Government of India has introduced the Eligible Manufacturer Importer (EMI) Scheme as part of the Union Budget 2026–27, offering a trust-based facilitation framework for deferred customs duty payments.

🗓 Effective Period: 1 April 2026 to 31 March 2028

This initiative allows approved manufacturers and importers to defer payment of customs import duties until prescribed monthly due dates — significantly improving working capital efficiency and strengthening ease of doing business.

🔎 Key Benefits

✔ Deferred customs duty payment (improved cash flow)
✔ Reduced immediate working capital blockage
✔ Encouragement for AEO upgradation
✔ Streamlined and compliant import operations

✅ Eligibility Criteria (Key Highlights)

• Must qualify as an importer and manufacturer under relevant tax laws
• Valid IEC required
• Minimum EXIM transaction threshold (25 documents; 10 for MSMEs)
• Aggregate annual turnover exceeding ₹5 crore (preceding FY)
• Active GST registration declaring manufacturing activity
• Clean compliance record with no major pending tax liabilities
• CA-certified financial solvency

📝 Application Process

• Apply online via the AEO portal (https://zurl.co/oxCwX)
• Upload prescribed documents and declarations
• Approval granted by Directorate of International Customs (DIC), CBIC
• Post-approval integration through ICEGATE for deferred payment facility

The EMI Scheme is particularly beneficial for mid-sized and growing manufacturing importers seeking improved liquidity while maintaining strong compliance standards.

For businesses regularly importing raw materials, capital goods, or inputs, this scheme presents a valuable opportunity to optimize cash flow without compromising regulatory discipline.

If you would like a detailed eligibility checklist or advisory note for implementation, feel free to connect.

02/01/2026

📢 Hiring – Article Assistants
H A V N & Company, Chartered Accountants – Patiala Office

H A V N & Company, Chartered Accountants, invites applications from sincere and motivated CA students for Articleship Training at our Patiala office, in accordance with ICAI guidelines. We offer a supportive and structured learning environment for students aiming to build a strong professional foundation.

🔍 Areas of Exposure

During your Articleship, you will gain hands-on experience in:

Statutory & Tax Audits

Income Tax & GST Compliance

Accounting & Financial Reporting

ROC and Other Regulatory Filings

Consulting & Advisory Assignments

Bank Audits

We are committed to ensuring quality training, professional discipline, and continued learning throughout your journey with us.

📌 Eligibility

Applicants should be:

Students who have cleared one or both groups of CA Intermediate, as per ICAI regulations.

💼 Stipend

Up to ₹10,000 per month, depending upon the capability, skillset, and performance of the candidate.

📍 Location

Patiala, Punjab

📄 How to Apply

Interested candidates may kindly share their updated resume at:
📧 [email protected]

📱 9814054949

We look forward to welcoming enthusiastic learners to our Patiala team at
H A V N & Company, Chartered Accountants.

Happy New Year to AllCA. Amol GuptaPartnerH A V N & COMPANYChartered Accountants
01/01/2026

Happy New Year to All
CA. Amol Gupta
Partner
H A V N & COMPANY
Chartered Accountants

🌟 EPF (Employees' Provident Fund) Withdrawal Before 5 Years — Taxability & Standard Deduction (Updated for FY 2024–25)Pr...
11/12/2025

🌟 EPF (Employees' Provident Fund) Withdrawal Before 5 Years — Taxability & Standard Deduction (Updated for FY 2024–25)

Premature EPF withdrawal (before completing 5 years of continuous service) triggers taxation. However, each component of the EPF balance is taxed differently, and the standard deduction varies based on the tax regime.

🔹 1. Non-Taxable Component
Employee’s own PF contribution
(Already contributed from taxed income; not taxable on withdrawal)

🔹 2. Taxable as Salary Income – Section 17(1)
These portions of the EPF relate to the employer and are treated as salary:
Employer’s contribution
Interest on employer’s contribution

✔ Standard Deduction Applicable
₹75,000 under the New Tax Regime (from FY 2024–25 onward)
₹50,000 under the Old Tax Regime

🔹 3. Taxable as Income From Other Sources (IFOS)
Interest on employee’s own PF contribution

This is not salary income and therefore:
✘ Not eligible for standard deduction

🔹 4. TDS on EPF Withdrawal – Section 192A
Withdrawal above ₹50,000 → TDS @ 10%
If PAN not provided → TDS @ 20%
TDS is deducted by EPFO, not the employer

🎯 Professional Insight
EPF withdrawal before 5 years is not entirely taxable, but correct segregation between Salary and IFOS is crucial for accurate ITR reporting.
Only the salary-linked components qualify for the standard deduction—
👉 ₹75,000 in the New Regime
👉 ₹50,000 in the Old Regime

Misclassification is one of the most common reasons for ITR mismatches and tax notices.

For Queries please connect at 9814106768, 8568859771, [email protected]
Thanks,
CA. AMOL GUPTA
Partner
H A V N & Company
Chartered Accountants

05/12/2025

Strengthening India’s Medical Device Ecosystem 🇮🇳 | Key Highlights of the SMDI Guidelines & Corrigendum (2025)

The Department of Pharmaceuticals has released the Operational Guidelines for the Scheme for Strengthening of Medical Device Industry (SMDI), along with a Corrigendum dated 09 June 2025.
This ₹500 crore scheme marks a transformative step toward building self-reliance, deepening domestic value chains, and enabling world-class capabilities in the MedTech sector.

🔍 Key Takeaways
✔ Support for Common Facility Centres (CFCs) and Testing Facilities, enabling clusters to access shared R&D, prototyping, sterilization, tool rooms, and advanced diagnostic testing facilities.
✔ Capital subsidy up to ₹10 crore for manufacturing key components, raw materials, and accessories to reduce import dependence.
✔ Funding for MedTech education through PG courses, diploma and short-term training programs—strengthening the skilled workforce pipeline.
✔ Support for clinical studies, including pre-clinical, clinical investigations, and performance evaluations for IVDs.
✔ Backing for industry promotion, such as expos, international missions, and manufacturer evaluation studies.

🆕 Corrigendum Highlights (09.06.2025)
• Reimbursement for training programs now allowed as and when expenditure is incurred.
• Institutions will receive quarterly student-related reimbursements.
• Non-recurring expenditure already incurred will not be required to be refunded if a program is discontinued.
• New minimum student intake criteria for continuation of support (30% in Year 1; 50% thereafter).

This is a significant opportunity for:
👉 Medical device manufacturers
👉 Testing laboratories
👉 Research institutions
👉 Universities and training centers
👉 Startups and innovators in MedTech

India’s MedTech sector is entering a new era of growth, innovation, and global competitiveness.

03/12/2025

🩺Production Linked Incentive (PLI) Scheme specially designed for the pharmaceutical industry. This initiative by the Government of India is a major push toward Atmanirbhar Bharat.

📌 What’s in the presentation?
✔ Objective of the PLI Scheme
✔ Categories of covered pharma products
✔ Eligibility criteria & application process
✔ Incentive structure & financial caps
✔ Role of APIs & national impact.

📧 Email: [email protected]
📞 Contact: +91-98141 06768

30/11/2025

🚀 Understanding the PLI Scheme for Pharmaceuticals – A Step Towards Atmanirbhar Bharat 🇮🇳

Namaskar professionals and industry colleagues,
I’m CA Amol Gupta, and today I’d like to highlight one of the Government of India’s most strategic initiatives — the Production Linked Incentive (PLI) Scheme for the pharmaceutical sector.

Launched by the Department of Pharmaceuticals, this scheme is designed to:

✅ Boost domestic manufacturing of high-quality medicines
✅ Reduce import dependency on critical APIs and drug ingredients
✅ Promote investment in advanced formulations, biosimilars, and complex generics

🔍 Who can apply?
Indian registered pharma manufacturers, grouped as:

Group A: ₹5,000+ Cr revenue

Group B: ₹500 – ₹5,000 Cr

Group C: Below ₹500 Cr (includes MSMEs)

📄 Applications are submitted online with investment plans, company details, and product information.

💸 What are the incentives?

10% incentive on incremental sales for Category 1 & 2 products

5% for Category 3

Tenure: 6 years (FY 2022–23 to 2027–28)

Max benefit: ₹1,200 Cr (Group A), ₹300 Cr (Group B), ₹60 Cr (Group C)

🌍 India is a global pharma exporter — but still dependent on imports for key APIs.
This scheme is a strong push toward self-reliance and value chain localization.

Let’s encourage awareness around such forward-looking policies that align business incentives with national development goals.

🔗 If you’re in pharmaceuticals, manufacturing, policy, or consulting — this is a space to watch closely.

📣 I’ll be covering more government-backed incentives and manufacturing policy updates soon.
Follow my page for industry insights.

25/11/2025

📢 We Are Hiring CA Articles! | H A V N & Company, Chartered Accountants

H A V N & Company, Chartered Accountants, is pleased to invite applications for Articleship Training in line with the ICAI Guidelines. We are looking for dedicated and enthusiastic CA Students who are eager to build a strong professional foundation and gain diverse practical exposure.

🔍 What You Will Learn

At H A V N & Company, you will receive comprehensive training across:

Statutory & Tax Audits

Income Tax & GST Compliance

Accounting & Financial Reporting

ROC and Other Regulatory Filings

Consulting & Advisory Assignments

Our team is committed to providing quality learning, professional discipline, and a supportive environment to help you grow throughout your Articleship journey.

📌 Eligibility

Students who have cleared CA Foundation and are eligible for Articleship, or

Students who have cleared one/both groups of CA Intermediate as per ICAI regulations.

📍 Office Locations

📍 New Delhi | Chandigarh | Patiala | Nabha

📄 How to Apply

Interested candidates may share their updated resume at:
📧 [email protected]

📱 9814054949

Come join us and take the next step in your CA career with H A V N & Company!

15/11/2025

Understanding Regarding AIF | Bank Finance

12/11/2025

New Rule 14A : GST Registration on Fast Track
Amol Gupta Kinsmen Corporate Services Zoho

08/11/2025

Understanding regarding Advance Tax under Income Tax Act, 1961
Amol Gupta Kinsmen Corporate Services

Address

Nabha
147201

Website

Alerts

Be the first to know and let us send you an email when H A V N & Company posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category